Target intelligence / Profile preview

Docosahexaenoic acid incorporation into membrane phospholipids

Molecular classification
Other
01

Overview

Incorporation of docosahexaenoic acid into membrane phospholipids, particularly glycerophospholipids such as phosphatidylethanolamine (PE) and phosphatidylserine (PS), substantially influences the fluidity and flexibility of cellular membranes[1][2]. DHA is highly enriched in the membranes of neuronal, retinal, cardiac, and reproductive tissues, where its unique structure due to multiple cis double bonds imparts increased membrane curvature and flexibility, facilitating dynamic processes such as membrane fusion and fission, and modulating conformational changes in membrane proteins[1]. In neurons, increased incorporation of DHA into PS promotes neuronal survival by supporting activation of the Akt signaling pathway, which reduces apoptotic cell death; conversely, depletion of DHA increases neuronal vulnerability[2]. The incorporation process is not a classical molecular therapeutic target such as a receptor or enzyme, but a physiological and metabolic phenomenon critical for normal tissue function and implicated in the pathophysiology of neurodegenerative, cardiovascular, and visual diseases[1][2].

Other names
DHA incorporation into membranesMembrane DHA incorporationDHA-phospholipid incorporation
02

Mechanism of action

Direct substrate for incorporation into phospholipids; Alters membrane physical properties to influence signaling pathways

03

Biological functions

Regulation of membrane fluidityModulation of membrane flexibilityFacilitation of membrane fusion and fissionRegulation of membrane protein conformationPromotion of neuronal survival
04

Disease associations

Neurodegenerative diseaseCardiovascular diseaseRetinal diseaseOther
05

Safety considerations

Excess incorporation could theoretically alter membrane dynamics, but clinical safety concerns are minimal at physiologic levels; possible caution in certain metabolic disorders
06

Interacting drugs

Docosahexaenoic acid (as a supplement or drug)
07

Biomarkers

Brain or neuronal membrane DHA contentPhosphatidylserine (PS) content in neuronal membranes

Beyond the preview

Go deeper on Docosahexaenoic acid incorporation into membrane phospholipids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Docosahexaenoic acid incorporation into membrane phospholipids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call